twitter-square
facebook-square
instagram
linkedin-square
tiktok
COVID-19
Long COVID
Children & Teens
Literature & Guidelines
Pathway for Referral
Provider Education
Recovery Needs
Resources
Services
Breast Health Centre
Diagnostic Services
Cadham Provincial Laboratory
Clinical Practice Changes
Continuing Education
Discipline Teams
Health Providers Feedback
Imaging Central Intake
Lab Information Manual
Point of Care Testing Training
Reference Material
Transfusion Manitoba
Transfusion Medicine
Update 24/7 Contact Information
Digital Health
Computer Training
Home Clinics
PCIS Office
Remote Access
Workforce ESP
Emergency Response Services
Infection Prevention & Control
Manitoba Poison Centre
Medical Assistance in Dying
Federal Reporting
Frequently Asked Questions
Guidance for Health Professionals
Mental Health & Addictions
Wellness & Health Booster Sessions
Research and Innovation
Resources
Accessing Supports & Services for Research
Tick Collaborative Care Service
Integration & Clinical Planning
Accreditation
Engagement
Events
Learning & Sharing
Measuring & Monitoring
Data Request Intake
Patient Safety
Make it Safe to Ask
Provincial Clinical Teams
Quality Improvement
Access Improvement Model
Lean Six Sigma
Project Intake
Medical Staff
Workplace Safety & Health
Careers
Home
>
Health Providers
>
Diagnostic
>
Clinical Practice Changes
>
Immunology
>
Anti-Phospholipase A2 Receptor (PLA2R)
Anti-Phospholipase A2 Receptor (PLA2R)
Dec. 13, 2021
File size: 107.83 KB
Created: 13-12-2021
Updated: 01-11-2022
Hits: 39
Preview File
Preview
©
Shared Health Inc.
All rights reserved. |
Site Map
|
Conditions of Use
|
Contact
This website is supported by
Digital Health
Top
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
Sitemap
Sitemap
